TRANSCODE THERAPEUTICS, INC. Public Float
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Public Float of $6.50 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $6.50M.
- 2024-06-30: Entity Public Float $7.30M.
- 2023-06-30: Entity Public Float $4.40M.
- 2022-06-30: Entity Public Float $11.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $6.50M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $7.30M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $4.40M 10-K · filed 2024-04-01 |
| 2022-06-30 | $11.00M 10-K · filed 2023-03-31 |
| 2021-07-13 | $32.53M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |